Venissieux, France

Charles Dumontet

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles Dumontet

Introduction

Charles Dumontet is a notable inventor based in Venissieux, France. He has made significant contributions to the field of pharmaceuticals, particularly in anti-tumor therapies and anti-allergic compounds. With a total of 3 patents to his name, Dumontet's work reflects a commitment to advancing medical science.

Latest Patents

Dumontet's latest patents include a liposomal formulation of bacterial lipopolysaccharide combined with a cytotoxic agent, which is aimed at enhancing anti-tumor therapy. This invention relates to a pharmaceutical combination product that has the potential to improve treatment outcomes for cancer patients. Another significant patent involves chalcone derivatives that exhibit anti-allergic activity, showcasing his versatility in addressing various health issues.

Career Highlights

Throughout his career, Dumontet has worked with esteemed organizations such as Hospices Civils De Lyon and the Centre National De La Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Dumontet has collaborated with notable colleagues, including Ahcene Boumendjel and Guillaume Monneret. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Charles Dumontet's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies, making a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…